News Search Results
May 13, 2025, 05:00 ET Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology
PARIS, May 13, 2025 /PRNewswire/ -- Eligo Bioscience, a biotechnology company pioneering the development of novel genetic medicines, today announced it has secured a $5 million grant from
More news about: Eligo Bioscience
May 12, 2025, 16:05 ET Tyra Biosciences to Participate at Upcoming Investor Conferences
May 12, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today
More news about: Tyra Biosciences
May 12, 2025, 16:05 ET REGENXBIO Reports First Quarter 2025 Financial Results and Recent Operational Highlights
Those who plan on participating are advised to join 15 minutes prior to the start time. ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
May 12, 2025, 13:59 ET SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, both dates inclusive
More news about: THE ROSEN LAW FIRM, P. A.
May 12, 2025, 13:39 ET INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANA
May 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) and certain officers. The class action, filed in the United States
More news about: Pomerantz LLP
May 12, 2025, 13:35 ET DELFI Diagnostics CTO Recognized among 2025 Most Influential Women in Bay Area Business
list in 2021, joined DELFI in December 2024 and has over two decades of experience working at the intersection of biotechnology and computational science. She boasts an impressive track record of developing breakthrough genomic technologies and products. As the CTO of DELFI
More news about: DELFI Diagnostics
May 12, 2025, 12:11 ET ADAR1 Capital Management Releases Investor Presentation Outlining Its Rationale for Withholding Votes From Directors Dr. Mary Ann Gray and Dr. Alpna Seth
investment manager based in Austin, Texas, focused on public and private equity investments in the life sciences and biotechnology sectors. The firm was founded in October 2018 by Dr. Daniel Schneeberger, who brings
More news about: ADAR1 Capital Management LLC
May 12, 2025, 11:30 ET Point Of Care Diagnostics Market Size to be $68.5 Billion by 2030 at CAGR 5.8% - Grand View Research, Inc.
BiotechSekisui DiagnosticsOrasure Technologies, Inc.Spectral Medical, Inc.EKF Diagnostics Holdings plc.Anbio Biotechnology Co., Ltd.AccuBioTech Co., LtdALPHA LABORATORIES.Check out more related studies published by Grand View Research:
More news about: Grand View Research, Inc
May 12, 2025, 11:23 ET The Lockwood Group Welcomes IDEOlogy Health - Accelerating its Leadership Role in Community Oncology
Lockwood GroupThe Lockwood Group is a global pharma services organization with over 600 employees, that partners with pharmaceutical and biotechnology companies to translate complex science into compelling strategies that drive clinical and commercial success. Learn more at
More news about: The Lockwood Group
May 12, 2025, 10:30 ET Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub
Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche Diagnostics
May 12, 2025, 10:01 ET ASEAN Point of Care Diagnostics Market worth $1.36 billion by 2030 with 4.7% CAGR | MarketsandMarkets™
Co., Ltd. (China), Credo Diagnostics Biomedical Pte. Ltd. (Singapore), Anbio Biotechnology Inc. (Germany), and SG Diagnostics (Singapore). Abbott (US):
More news about: MarketsandMarkets
May 12, 2025, 09:50 ET SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sana Biotechnology, Inc. ("Sana" or "the Company") (NASDAQ:
More news about: The Schall Law Firm
May 12, 2025, 09:15 ET TriNet Launches "Your Path, Our Purpose" Brand Campaign Celebrating the Inspiring Journeys of Small and Medium-Size Businesses
Zymo Research – Since 1994, Zymo Research has been a global leader in biotechnology, advancing cutting-edge discoveries in epigenetics, microbiomics, and Next-Gen Sequencing. With its innovative tools and global reach, Zymo empowers
More news about: TriNet
May 12, 2025, 09:05 ET BioMarin Presents New Data for VOXZOGO® (vosoritide) in Children with Achondroplasia and Other Skeletal Conditions at Two International Endocrinology Meetings
Patient Information. About BioMarin BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.
May 12, 2025, 09:04 ET MavriX Bio Announces FDA Clearance of IND Application to Initiate First-in-Human Study of Gene Therapy for Angelman Syndrome
Mass., May 12, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the U.S. Food and Drug Administration
More news about: MavriX Bio
May 12, 2025, 08:32 ET True Indicating Receives FDA Approval for CSPN-15 Type 5 Steam Integrator
monitoring products and expert services to medical device manufacturers, healthcare, dental, lab services, industrial, pharmaceutical, life science, and biotechnology companies. With over 35 years of combined experience, our focus is science-based service, allowing us to identify True solutions and True partnerships
More news about: True Indicating
May 12, 2025, 08:30 ET Grit Biotechnology Presents Multiple Scientific Breakthroughs at ASGCT 2025 Annual Meeting
SHANGHAI, May 12, 2025 /PRNewswire/ -- Grit Biotechnology Co., Ltd. ("Grit Bio"), a clinical-stage biotech pioneering novel immunotherapies announced today that three research
More news about: Grit Biotechnology
May 12, 2025, 08:00 ET Kimera® Labs Named Semifinalist in $101 Million XPRIZE Healthspan Competition for Pioneering Innovations in Healthy Aging
Leading Exosome Biotechnology Company Advances in Global Effort to Extend Healthy Human Lifespan MIRAMAR, Fla., May 12, 2025 /PRNewswire/
More news about: Kimera Labs Inc
May 12, 2025, 08:00 ET Kimera® Labs Named Semifinalist in $101 Million XPRIZE Healthspan Competition for Pioneering Innovations in Healthy Aging
Leading Exosome Biotechnology Company Advances in Global Effort to Extend Healthy Human Lifespan MIRAMAR, Fla., May 12, 2025 /PRNewswire/
More news about: Kimera Labs Inc
May 12, 2025, 08:00 ET Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Dr. Pamela D. Garzone, Chief Development
More news about: Anixa Biosciences, Inc.
May 12, 2025, 08:00 ET Ted Myles Joins Cellarity as Chief Executive Officer
Pioneering. "On behalf of the entire Board, we welcome Ted and look forward to a fruitful partnership." "Cellarity is a powerhouse of AI-powered biotechnology as it brings data, biology, and chemistry together in truly distinctive ways. I am impressed by the strength of its end-to-end platform and the
More news about: Flagship Pioneering
May 12, 2025, 08:00 ET Synthego Introduces GMP SpCas9 to Accelerate Gene Editing for Therapeutic Advancement
contacting our experts to start your GMP project. About SynthegoSynthego is a leader in biotechnology, dedicated to delivering best-in-class CRISPR solutions with a mission to accelerate research and development in the pursuit of improved human health.
More news about: Synthego
May 12, 2025, 07:30 ET Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value
(as of April 17, 2025, the date Dynavax filed its definitive proxy) while vaccine peers returned 9% and the S&P Biotechnology Select Industry Index declined 17% over the same period.Dynavax successfully commercialized and positioned HEPLISAV-B® to be the market-leading
More news about: Dynavax Technologies
May 12, 2025, 07:00 ET Origin Agritech Hosts Core Customer Symposium in Zhengzhou Kicking-off New Season's Demonstration and Promotion Activities
of new varieties and biotechnology products to our core distributor network, we are accelerating market adoption while gathering valuable feedback that will guide our future research and development efforts." The exhibition field featured dedicated zones for biotechnology product displays, cooperative
More news about: Origin Agritech Limited
May 12, 2025, 05:45 ET Sana Biotechnology, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before May 20, 2025 to Discuss Your Rights - SANA
May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA).
More news about: The Gross Law Firm